Between 1998 and 2003 the rate of erythromycin resistance among pneumococci in Spain was 34.4%. Although the MLS B phenotype was prevalent (94.7%), the rate of the M phenotype increased from 3.3% to 8.9% (P < 0.01). Clonal dissemination of mef(E)-carrying strains of serotype 14 variant of the Spain 9V -3 clone was the major contributor to this increase.
Increased resistance to macrolide in Streptococcus pneumoniae has been described worldwide (8-10, 14-16, 18-21, 23-27) . In Europe, Mediterranean countries have the highest rates of erythromycin-resistant pneumococci, whereas northern European countries have the lowest (14-16, 20, 23, 29) . In Spain, the rate of erythromycin resistance has increased progressively, from 4.3% in the period from 1979 to 1990 (19) to 22.5% in the period from 1990 to 1996 (14) and 34 .5% in 2001 and 2002 (26) .
Macrolide resistance in pneumococci is mainly mediated by two mechanisms: enzymatic target site modifications mediated by ErmB methylases that confer the MLS B phenotype and active drug efflux pumps encoded by mef genes that confer the M phenotype. Other less frequent mechanisms have also been described: point mutations in ribosomal proteins L4 and L22 or in 23S rRNA (17, 28) . The MLS B phenotype is prevalent in Spain and in most European countries, whereas the M phenotype predominates in North America, England, and Greece (1, 8, 15, 21, 29) .
In this paper, macrolide-resistant pneumococci with the M phenotype from Spain were investigated.
Evolution of macrolide resistance in pneumococci. Among 15,084 pneumococci recorded at the Spanish Reference Laboratory (1998 to 2003), 5,194 (34.4%) were erythromycin resistant. By the disk diffusion method (31) 4,917 (94.7%) showed the MLS B phenotype and 277 (5.3%) showed the M phenotype (134 isolates were from blood, 55 were from the lower respiratory tract, 20 were from patients with otitis, 21 were from patients with conjunctivitis, and 47 were from miscellaneous sources). Table 1 shows the evolution of rates of erythromycin resistance and the phenotypes. Although the MLS B phenotype is dominant among erythromycin-resistant pneumococci, our study shows that the proportions of isolates with the M phenotype increased significantly from 3.3% in 1998 to 8.9% in 2003 (P Ͻ 0.01) ( Table 1) . Similar rates of the M phenotype were found among erythromycin-resistant isolates from children (age, Ͻ15 years) and adults (4.6% and 5.1%, respectively).
Resistance genes. Classically, two mef genes have been identified in pneumococci, mef(A) and mef(E), and these are carried by different genetic elements (6 Consistent with the findings of previous studies (1, 17), we found that the erythromycin MICs of mef(A)-carrying pneumococci were higher (range, 8 to 128 g/ml; geometric mean, 29.0 g/ml) than those of mef(E)-carrying strains (range, 2 to 128 g/ml; geometric mean, 12.9 g/ml). These findings could be due to structural differences in the protein or at the site of codifying genes (1). (M) and int genes by PCR (1, 7)] and had unrelated pulsed-field gel electrophoresis (PFGE) patterns. The association of the mef(E) and the tet(M) genes was reported previously (1, 25, 30) , and the genetic element harboring both genes, Tn2009, was recently described (7) .
Serotypes and genotypes related to mef genes. Serotyping and PFGE (SmaI) were performed with all mef-carrying isolates, as described previously (14, 22, 33) . Twelve strains with the dominant PFGE patterns were selected for multilocus sequence typing (MLST) (12) .
Nineteen different serotypes were found among 242 mef(E)-carrying isolates, with the most frequent being serotype 14 (55.8%), nontypeable (10.3%), and serotype 11A (7.9%). Ninety-two PFGE patterns were observed among the mef(E)-carrying strains, with the Spain 9V -3 clone (55.8%) and genotype 11A-ST62 (7.0%) being the major clones found ( (21), and all but one were of serotype 9V. In contrast, we found that 96.3% of the mef(E)-carrying pneumococci of the Spain 9V -3 clone were serotype 14, demonstrating a phenomenon of capsular switching between serotypes 9V and 14.
The England 14 -9 clone harboring mef(A) has been described as predominant among M-phenotype pneumococci isolated in England, Italy, and Greece (1, 6, 15, 24) . In our study this clone ranked second. In contrast, the strains of the England 14 -9 clone described in the United States carried the mef(E) gene (21) .
Strains of serotype 11A with ST62 have previously been found in Spain among erythromycin-susceptible pneumococci causing meningitis (11) . Our results show that isolates of ge- (9) and Canada (34) . In common with other findings (34), our results show that a third of the mef(E) isolates had unrelated genotypes, thus suggesting the horizontal spread of this gene. We previously reported a high prevalence of macrolide resistance mediated by the mef(E) gene in viridans group streptococci (2), which may act as a reservoir of the mef(E) gene and contribute to the horizontal transmission of macrolide resistance in pneumococci, as is the case in other resistance genes (3).
In conclusion, although the mef(E) gene may spread horizontally, the clonal dissemination of the serotype 14 variant of the Spain 9V -3 clone harboring the mef(E) gene is a major contributor to the emergence of M-phenotype pneumococci in Spain. 
